
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Victor Chan, MBA, MS, director of U.S. Surgical Device Commercial Marketing at Santen, Inc., offers insight on the Glaucoma Devices panel discussion regarding new innovations and diagnostic devices during Glaucoma 360 2020 in San Francisco, California.






